Skip to content
Trial Eligibility
Menu

Human Blood Cell Disorders Tissue Bank

NCT00902447

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The Human Blood Cell Disorder Tissue Bank will provide a convenient, comprehensive source of tissue containing populations of human blood cells from patients with various types of lymphoid, myeloid, and erythroid proliferative diseases as well as other associated conditions. The tissue bank will continue to be an invaluable asset for understanding of the biology of multiple blood cell disorders involving several cell types as well as the physiology of normal cellular counterparts affected in these disorders.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Human Blood Cell Disorders
  • Lymphoid, Myeloid and Erythroid Proliferative Disease

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 100 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Northwell Health
Last updated on ClinicalTrials.gov
March 27, 2024

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • The Feinstein Institute for Medical Research · Manhasset, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.